Takeda Pharmaceutical Company Limited (TAK)

Healthcare · Drug Manufacturers Specialty Generic · NYSE

Takeda Pharmaceutical Company Limited (TAK) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $55.73B, a trailing price-to-earnings ratio of 35.2 and a free-cash-flow yield of 7.3%. Over the most recent reported fiscal year, revenue declined 1.7% and free cash flow per share fell 5.7%.

Market cap	$55.73B
Trailing P/E	35.2
FCF yield	7.3%
Revenue growth (YoY)	-1.7%
EPS growth (YoY)	—
FCF/share growth (YoY)	-5.7%
Exchange	NYSE
Sector	Healthcare
Industry	Drug Manufacturers Specialty Generic

Explore live TAK data on Nama Insights →

Recent Congressional trades

Takeda Pharmaceutical Company Limited trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Virginia Foxx	House	Buy	$1,001 - $15,000	Mar 1, 2023
Virginia Foxx	House	Buy	$1,001 - $15,000	Nov 1, 2022
Nicholas Van Taylor	House	Sell	$15,001 - $50,000	Mar 25, 2019
Greg Gianforte	House	Buy	$15,001 - $50,000	Dec 26, 2018